Sun Pharma latest to sell COVID-19 drug favipiravir in India, to cost Rs 35 per tablet

Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in India, which saw a surge of 50,000-plus infections for the sixth straight day on Tuesday. Sun's version of favipiravir, to be called FluGuard, will cost 35 rupees per 200 mg tablet, making it the cheapest version available.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2EPf4yF
via IFTTT